A Genus-Wide Bioactivity Analysis of Daboia (Viperinae: Viperidae) Viper Venoms Reveals Widespread Variation in Haemotoxic Properties
Open Access
- 15 December 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (24) , 13486
Abstract
The snake genus Daboia (Viperidae: Viperinae; Oppel, 1811) contains five species: D. deserti, D. mauritanica, and D. palaestinae, found in Afro-Arabia, and the Russell’s vipers D. russelii and D. siamensis, found in Asia. Russell’s vipers are responsible for a major proportion of the medically important snakebites that occur in the regions they inhabit, and their venoms are notorious for their coagulopathic effects. While widely documented, the extent of venom variation within the Russell’s vipers is poorly characterised, as is the venom activity of other species within the genus. In this study we investigated variation in the haemotoxic activity of Daboia using twelve venoms from all five species, including multiple variants of D. russelii, D. siamensis, and D. palaestinae. We tested the venoms on human plasma using thromboelastography, dose-response coagulometry analyses, and calibrated automated thrombography, and on human fibrinogen by thromboelastography and fibrinogen gels. We assessed activation of blood factors X and prothrombin by the venoms using fluorometry. Variation in venom activity was evident in all experiments. The Asian species D. russelii and D. siamensis and the African species D. mauritanica possessed procoagulant venom, while D. deserti and D. palaestinae were net-anticoagulant. Of the Russell’s vipers, the venom of D. siamensis from Myanmar was most toxic and D. russelli of Sri Lanka the least. Activation of both factor X and prothrombin was evident by all venoms, though at differential levels. Fibrinogenolytic activity varied extensively throughout the genus and followed no phylogenetic trends. This venom variability underpins one of the many challenges facing treatment of Daboia snakebite envenoming. Comprehensive analyses of available antivenoms in neutralising these variable venom activities are therefore of utmost importance.Keywords
Funding Information
- Australian Research Council (DP190100304)
- Wellcome (200517/Z/16/Z)
- Royal Society of Medicine (200517/Z/16/Z)
- Higher Education Commission, Pakistan (PDRF Phase II Batch-V; NRPU No.20-3891)
This publication has 61 references indexed in Scilit:
- Snake venomics of Macrovipera mauritanica from Morocco, and assessment of the para-specific immunoreactivity of an experimental monospecific and a commercial antivenomsJournal of Proteomics, 2012
- The Global Burden of Snakebite: A Literature Analysis and Modelling Based on Regional Estimates of Envenoming and DeathsPLOS Medicine, 2008
- P-III hemorrhagic metalloproteinases from Russell's viper venom: Cloning, characterization, phylogenetic and functional site analysesBiochimie, 2008
- Thrombin generation, fibrin clot formation and hemostasisTransfusion and Apheresis Science, 2008
- Thrombin generation and fibrin clot structureBlood Reviews, 2007
- Structural models of the snake venom factor V activators from Daboia russelli and Daboia lebetinaProteins: Structure, Function, and Bioinformatics, 2006
- Vipera palaestinae envenomation-induced bradycardiaEuropean Journal of Internal Medicine, 2004
- Delayed Administration ofVipera xanthina palaestinaeAntiveninJournal of Toxicology: Clinical Toxicology, 1997
- Protein and cDNA Structures of an Acidic Phospholipase A2, the Enzymatic Part of an Unusual, Two-Component Toxin fromVipera palaestinaeBiochemical and Biophysical Research Communications, 1996
- Diet and snake venom evolutionNature, 1996